As a result of attending this session, participants will be able to:
Understand the differences between Ho:YAG and Tm-fiber lasers
Understand the benefits on tm-fiber laser
Use tm-fiber laser for stone treatment
Thulium Fiber Laser: from the Lab to Clinical Practice
Olivier Traxer
University of Paris 6th, Paris, France
Bio
Dr Olivier TRAXER is Professor of Urology : University of Paris 6th (Pierre et Marie Curie) and works in Tenon Hospital. He did a research-fellowship at Southwestern Medical School, University of Texas, Dallas-USA (Charles Y.C PAK & Margaret Sue PEARLE) to sub-specialize in Endourology and kidney stone management. As endo-urologist, his main goal is to improve the knowledge on urinary stone disease and endourology. PrTraxer Olivier is responsible in Tenon Hospital (University Pierre et Marie Curie Paris-6) of the minimally invasive surgery section and published more than 250 peer-reviewed papers. Pr Traxer is a board member of the EndoUrological Society, the French Association of Urology (AFU) and EAU board member of the EULIS, ESUT and ESU office. He is also the treasurer of SIU. He received in 2010 (Chicago-WCE) the Arthur Smith Award.
Dr. Naeem Bhojani was born and raised in Montreal, Quebec. He obtained a Bachelor of Science in Microbiology and Immunology and another in Physiotherapy from McGill University in 2001 and then completed medical school at the University of Montreal in 2006. He stayed on to do his residency at the University of Montreal finishing in 2011 before moving to Indianapolis, Indiana to spend 2 years with Dr. Lingeman at Indiana University completing his Fellowship in BPH and Stone Disease. Dr. Bhojani was recruited by The University of Montreal in 2013 to build and develop Comprehensive Kidney Stone and BPH Programs. At the University of Montreal, he has the rank of Associate Professor, Pedagogic Leader and clinical rechercher. Dr. Bhojani has published extensively in stone disease and new BPH technologies. Clinically, Dr. Bhojani is currently working on optimizing kidney stone prevention, perfecting ultrasound guided PCNL access as well as exploring new BPH technologies.
As a result of attending this session, participants will be able to:
Describe and recognize Canadian contributions to Endourology
Describe new methods of stone fragmentation including ultrasonic Breakwave energy and thulium fiber laser
Understand the new horizons of endourology including robotic ureteroscopy and electromagnetic percutaneous renal access
Introducer/Moderator: Anil Kapoor
Advances in Kidney STone Surgery Since the Turn of the Century
Ben Chew
University of British Columbia, Vancouver, BC
Bio
Dr. Chew is a urologist and the Director of Clinical Research at the Stone Centre at Vancouver General Hospital and an Associate Professor of Urology at the University of British Columbia in Vancouver, Canada. He is also the Chair of Research for the Endourological Society (www.endourology.org ). His main interests lie in the treatment and research of the pathophysiology of kidney stone disease. His research focus includes metabolic stone disease as well as biomaterials used in the urinary tract for ureteral stents. He has worked on various stent designs, stent coatings and drug-eluting ureteral stents to try and improve the quality of life for patients with kidney stone disease. He continues work on a degradable ureteral stent and has completed the first-in-human trials. Current studies include attempting to understand second messenger systems that are activated within the kidney and ureter once a ureteral stent has been placed. These could be exploited as future therapeutic targets for new drug eluting ureteral stents or designs to reduce symptoms. He has authored over 90 peer-reviewed manuscripts and book chapters. He is a member of the Endourologic Disease Group for Excellence (EDGE) research consortium (www.endoedge.net) and the Wisconsin Quality of Life (WISQoL) research consortium.
This web site is provided as a convenience to you and is for informational purposes only. The information on or available through this web site is not a substitute for professional medical care by a qualified doctor or other health care professional.
CUA Corporate Office
185 Dorval Avenue, Suite 401
Dorval, Quebec H9S 5J9
Tel: +1 514 395 0376
Fax: +1 514 395 1664 This email address is being protected from spambots. You need JavaScript enabled to view it.